ADAR1 Capital Management »

Tenaya Therapeutics shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Tenaya Therapeutics (TNYA) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Tenaya Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tenaya Therapeutics held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tenaya Therapeutics by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.1M 1.5M 0.71

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Avidity Biosciences Ord (RNA)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Arbutus Biopharma (ABUS)
Zai Lab Adr (ZLAB)
Terns Pharmaceuticals (TERN)
Cytomx Therapeutics (CTMX)
Celldex Therapeutics Com New (CLDX)
Rapt Therapeutics Com New (RAPT)

View all positions for ADAR1 Capital Management

Top funds holding Tenaya Therapeutics

Column Group
Vanguard Group
Empery Asset Management
Millennium Management
Frigate Ventures
Alyeska Investment Group
BlackRock
Renaissance Technologies
ADAR1 Capital Management
Sphera Funds Management
GSA Capital Partners
Marshall Wace
Geode Capital Management
Euclidean Capital
Alphabet

View all funds holding Tenaya Therapeutics